Share Prices & Company Research

Market News

23 Mar 2021 | 11:38

Pfizer to research using mRNA technology against other viruses

(Sharecast News) - Pfizer will strike out on its own to develop vaccines against viruses other than SARS-CoV-2 using the the same mRNA technology used against the novel coronavirus. Its Covid-19 shot was developed alongside Germany's BioNTech, one of the earliest pioneers of the technology, which researchers believe likely has applications and uses far beyond the novel coronavirus.

The company's plans were disclosed by Pfizer boss, Albert Bourla, in an interview with the Wall Street Journal.

Bourla reportedly did not disclose which specific viruses Pfizer would target.

Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.